Suppr超能文献

肿瘤细胞驱动的细胞外基质重塑在转移进展过程中驱动趋触性。

Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.

作者信息

Oudin Madeleine J, Jonas Oliver, Kosciuk Tatsiana, Broye Liliane C, Guido Bruna C, Wyckoff Jeff, Riquelme Daisy, Lamar John M, Asokan Sreeja B, Whittaker Charlie, Ma Duanduan, Langer Robert, Cima Michael J, Wisinski Kari B, Hynes Richard O, Lauffenburger Douglas A, Keely Patricia J, Bear James E, Gertler Frank B

机构信息

David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts.

Lineberger Comprehensive Cancer Center, UNC Chapel Hill, Chapel Hill, North Carolina.

出版信息

Cancer Discov. 2016 May;6(5):516-31. doi: 10.1158/2159-8290.CD-15-1183. Epub 2016 Jan 25.

Abstract

UNLABELLED

Fibronectin (FN) is a major component of the tumor microenvironment, but its role in promoting metastasis is incompletely understood. Here, we show that FN gradients elicit directional movement of breast cancer cells, in vitro and in vivo Haptotaxis on FN gradients requires direct interaction between α5β1 integrin and MENA, an actin regulator, and involves increases in focal complex signaling and tumor cell-mediated extracellular matrix (ECM) remodeling. Compared with MENA, higher levels of the prometastatic MENA(INV) isoform associate with α5, which enables 3-D haptotaxis of tumor cells toward the high FN concentrations typically present in perivascular space and in the periphery of breast tumor tissue. MENA(INV) and FN levels were correlated in two breast cancer cohorts, and high levels of MENA(INV) were significantly associated with increased tumor recurrence as well as decreased patient survival. Our results identify a novel tumor cell-intrinsic mechanism that promotes metastasis through ECM remodeling and ECM-guided directional migration.

SIGNIFICANCE

Here, we provide new insight into how tumor cell:ECM interactions generate signals and structures that promote directed tumor cell migration, a critical component of metastasis. Our results identify a tumor cell-intrinsic mechanism driven by the actin regulatory protein MENA that promotes ECM remodeling and haptotaxis along FN gradients. Cancer Discov; 6(5); 516-31. ©2016 AACR.See related commentary by Santiago-Medina and Yang, p. 474This article is highlighted in the In This Issue feature, p. 461.

摘要

未标记

纤连蛋白(FN)是肿瘤微环境的主要成分,但其在促进转移中的作用尚未完全明确。在此,我们发现FN梯度可引发乳腺癌细胞的定向运动,无论是在体外还是体内。在FN梯度上的趋触性需要α5β1整合素与肌动蛋白调节蛋白MENA之间的直接相互作用,并且涉及粘着斑信号传导的增加以及肿瘤细胞介导的细胞外基质(ECM)重塑。与MENA相比,促转移的MENA(INV)异构体水平更高,它与α5相关联,这使得肿瘤细胞能够在三维空间中朝着血管周围间隙和乳腺肿瘤组织周边通常存在的高FN浓度进行趋触性运动。在两个乳腺癌队列中,MENA(INV)和FN水平相关,并且高水平的MENA(INV)与肿瘤复发增加以及患者生存率降低显著相关。我们的结果确定了一种新的肿瘤细胞内在机制,该机制通过ECM重塑和ECM引导的定向迁移促进转移。

意义

在此,我们对肿瘤细胞与ECM的相互作用如何产生促进肿瘤细胞定向迁移(转移的关键组成部分)的信号和结构提供了新的见解。我们的结果确定了一种由肌动蛋白调节蛋白MENA驱动的肿瘤细胞内在机制,该机制促进ECM重塑以及沿FN梯度的趋触性。《癌症发现》;6(5);516 - 31。©2016美国癌症研究协会。见圣地亚哥 - 梅迪纳和杨的相关评论,第474页。本文在本期特刊第461页重点介绍。

相似文献

1
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.
Cancer Discov. 2016 May;6(5):516-31. doi: 10.1158/2159-8290.CD-15-1183. Epub 2016 Jan 25.
2
MenaINV mediates synergistic cross-talk between signaling pathways driving chemotaxis and haptotaxis.
Mol Biol Cell. 2016 Oct 15;27(20):3085-3094. doi: 10.1091/mbc.E16-04-0212. Epub 2016 Aug 24.
3
MENA Promotes Tumor-Intrinsic Metastasis through ECM Remodeling and Haptotaxis.
Cancer Discov. 2016 May;6(5):474-6. doi: 10.1158/2159-8290.CD-16-0231.
4
Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.
Matrix Biol. 2020 Jan;85-86:80-93. doi: 10.1016/j.matbio.2019.07.006. Epub 2019 Jul 16.
5
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
Cell Death Differ. 2016 Jan;23(1):132-45. doi: 10.1038/cdd.2015.78. Epub 2015 Jun 12.
6
5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.
J Cell Biol. 2016 Sep 12;214(6):719-34. doi: 10.1083/jcb.201501003. Epub 2016 Sep 5.
7
Characterization of the expression of the pro-metastatic Mena(INV) isoform during breast tumor progression.
Clin Exp Metastasis. 2016 Mar;33(3):249-61. doi: 10.1007/s10585-015-9775-5. Epub 2015 Dec 17.
9
Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
Matrix Biol. 2017 Jul;60-61:86-95. doi: 10.1016/j.matbio.2016.08.001. Epub 2016 Aug 6.

引用本文的文献

2
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.
J Transl Med. 2025 Jul 4;23(1):744. doi: 10.1186/s12967-025-06778-8.
4
Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets.
Cancer Med. 2025 May;14(9):e70901. doi: 10.1002/cam4.70901.
5
Haptotactic Motion of Multivalent Vesicles Along Ligand-Density Gradients.
Langmuir. 2025 May 13;41(18):11474-11485. doi: 10.1021/acs.langmuir.5c00494. Epub 2025 Apr 29.
7
Talin1 Ser425 phosphorylation promotes colorectal cancer progression and metastasis.
Transl Cancer Res. 2025 Feb 28;14(2):796-807. doi: 10.21037/tcr-24-1283. Epub 2025 Feb 26.
8
Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer.
Cancer Metastasis Rev. 2025 Feb 11;44(1):31. doi: 10.1007/s10555-025-10249-3.
9
Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.
In Vitro Model. 2023 Jan 27;2(1-2):1-23. doi: 10.1007/s44164-023-00043-2. eCollection 2023 Apr.
10
Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer.
Biomedicines. 2024 Nov 21;12(12):2653. doi: 10.3390/biomedicines12122653.

本文引用的文献

1
Characterization of the expression of the pro-metastatic Mena(INV) isoform during breast tumor progression.
Clin Exp Metastasis. 2016 Mar;33(3):249-61. doi: 10.1007/s10585-015-9775-5. Epub 2015 Dec 17.
2
Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin.
J Cell Biol. 2015 Sep 28;210(7):1165-84. doi: 10.1083/jcb.201506041. Epub 2015 Sep 21.
3
PTP1B-dependent regulation of receptor tyrosine kinase signaling by the actin-binding protein Mena.
Mol Biol Cell. 2015 Nov 1;26(21):3867-78. doi: 10.1091/mbc.E15-06-0442. Epub 2015 Sep 2.
4
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors.
Sci Transl Med. 2015 Apr 22;7(284):284ra57. doi: 10.1126/scitranslmed.3010564.
5
Mesenchymal chemotaxis requires selective inactivation of myosin II at the leading edge via a noncanonical PLCγ/PKCα pathway.
Dev Cell. 2014 Dec 22;31(6):747-60. doi: 10.1016/j.devcel.2014.10.024. Epub 2014 Dec 4.
7
The extracellular matrix modulates the hallmarks of cancer.
EMBO Rep. 2014 Dec;15(12):1243-53. doi: 10.15252/embr.201439246. Epub 2014 Nov 8.
8
LKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues.
J Cell Biol. 2014 Oct 27;207(2):299-315. doi: 10.1083/jcb.201404067.
10
CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.
Cancer Cell. 2014 Jan 13;25(1):21-36. doi: 10.1016/j.ccr.2013.12.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验